139 results
Page 4 of 7
8-K
EX-99.2
fgtdjp
29 Jan 19
Unregistered Sales of Equity Securities
5:25pm
424B5
28p0ox9w3tmog6xed3
29 Jan 19
Prospectus supplement for primary offering
5:24pm
424B5
8wwgx713e26dy
28 Jan 19
Prospectus supplement for primary offering
4:01pm
8-K
EX-1.1
39sfgher57si4
10 Jan 19
Cancer Genetics, Inc. Announces Proposed Public Offering of Common Stock
5:04pm
424B5
vzyffjmrx
10 Jan 19
Prospectus supplement for primary offering
5:01pm
424B5
azhd4843mz
9 Jan 19
Prospectus supplement for primary offering
4:02pm
425
3a6nmzub9n8hlboo6a3
18 Oct 18
Business combination disclosure
4:05pm
425
EX-99.1
u7vf 1sbpti3r
9 Oct 18
Business combination disclosure
8:48am
8-K
EX-99.1
7krxq6a
9 Oct 18
Cancer Genetics and Cellaria Partner on Precision Medicine Tools
8:47am
425
EX-2.1
vhqaixd
21 Sep 18
Business combination disclosure
4:06pm
425
EX-10.1
thubt k5kp2
21 Sep 18
Business combination disclosure
4:06pm
8-K
EX-10.1
dimrmrxs nqtc
21 Sep 18
Novellusdx Shareholder Voting Agreement
4:05pm
8-K
EX-2.1
9tdq9x8opmd cpt
21 Sep 18
Novellusdx Shareholder Voting Agreement
4:05pm
8-K
EX-10.1
nj5 eotzn
5 Jul 18
Entry into a Material Definitive Agreement
4:59pm
8-K
EX-10.1
awr8fp oe6whu
27 Jun 18
Entry into a Material Definitive Agreement
4:05pm
8-K
lqf8mqyz2k sm8ui
1 May 18
Departure of Directors or Certain Officers
8:45am